DK120390A - Nasal administration af benzodiazepinhypnotika - Google Patents

Nasal administration af benzodiazepinhypnotika Download PDF

Info

Publication number
DK120390A
DK120390A DK120390A DK120390A DK120390A DK 120390 A DK120390 A DK 120390A DK 120390 A DK120390 A DK 120390A DK 120390 A DK120390 A DK 120390A DK 120390 A DK120390 A DK 120390A
Authority
DK
Denmark
Prior art keywords
nasal administration
benzodiazepine hypnotics
benzodiazepine
nasal
hypnotics
Prior art date
Application number
DK120390A
Other languages
English (en)
Other versions
DK175710B1 (da
DK120390D0 (da
Inventor
Arthur H Goldberg
Original Assignee
Arthur H Goldberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22925038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK120390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arthur H Goldberg filed Critical Arthur H Goldberg
Publication of DK120390A publication Critical patent/DK120390A/da
Publication of DK120390D0 publication Critical patent/DK120390D0/da
Application granted granted Critical
Publication of DK175710B1 publication Critical patent/DK175710B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK199001203A 1988-09-16 1990-05-15 Nasal administration af benzodiazepinhypnotika DK175710B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24503188 1988-09-16
US07/245,031 US4950664A (en) 1988-09-16 1988-09-16 Nasal administration of benzodiazepine hypnotics
PCT/US1989/003897 WO1990002737A1 (en) 1988-09-16 1989-09-08 Nasal administration of benzodiazepine hypnotics
US8903897 1989-09-08

Publications (3)

Publication Number Publication Date
DK120390A true DK120390A (da) 1990-05-15
DK120390D0 DK120390D0 (da) 1990-05-15
DK175710B1 DK175710B1 (da) 2005-01-31

Family

ID=22925038

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199001203A DK175710B1 (da) 1988-09-16 1990-05-15 Nasal administration af benzodiazepinhypnotika

Country Status (12)

Country Link
US (1) US4950664A (da)
EP (1) EP0386232B2 (da)
JP (1) JP2729525B2 (da)
KR (1) KR920005965B1 (da)
AT (1) ATE125799T1 (da)
AU (1) AU640618B2 (da)
CA (1) CA1336502C (da)
DE (1) DE68923697T3 (da)
DK (1) DK175710B1 (da)
IL (1) IL91656A0 (da)
NZ (1) NZ230653A (da)
WO (1) WO1990002737A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE36744E (en) * 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics
EP0532546B1 (en) * 1990-05-10 1998-03-18 Bechgaard International Research And Development A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5166202A (en) * 1990-09-19 1992-11-24 Trustees Of The University Of Pennsylvania Method for the treatment of panic disorder
CA2055308A1 (en) * 1990-11-29 1992-05-30 Roman Amrein Imidazobenzodiazepine for the treatment of sleep disorders
US5679580A (en) * 1994-03-09 1997-10-21 Midwest Research Institute Rapid evaporation method for analysis
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
WO1996011689A1 (en) * 1994-10-14 1996-04-25 Glaxo Wellcome Spa Use of cck-b receptor antagonists for the treatment of sleep disorders
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
DE60038738T2 (de) 1999-07-26 2009-07-02 Sk Holdings Co., Ltd. Transnasale anticonvulsive zusammensetzungen
SK11072002A3 (sk) * 1999-12-30 2003-03-04 H. Lundbeck A/S Halogénom substituované 4-fenyl-1-piperazinylové, -piperidinylové a -tetrahydropyridylové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
WO2002013886A2 (en) * 2000-08-15 2002-02-21 University Of Kentucky Research Foundation Programmable multi-dose intranasal drug delivery device
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
WO2002094218A2 (en) 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US7138107B2 (en) * 2003-02-18 2006-11-21 Compellis Pharmaceuticals Inhibition of olfactory neurosensory function to treat eating disorders and obesity
US20040241100A1 (en) * 2003-03-17 2004-12-02 Fabre Kramer Pharmaceutical, Inc. Nasally administrable compositions of zolpidem and methods of use
CA2529489C (en) * 2003-06-17 2012-01-03 Sk Corporation Transnasal microemulsions containing diazepam
GB0400804D0 (en) * 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US20060039869A1 (en) * 2004-08-17 2006-02-23 Daniel Wermeling Intranasal delivery of antipsychotic drugs
TW200824693A (en) * 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US7745430B2 (en) * 2006-11-15 2010-06-29 Sk Holdings Co., Ltd. Transnasal anticonvulsive pharmaceutical composition
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
WO2009027697A2 (en) * 2007-08-31 2009-03-05 Archimedes Development Limited Non-aqueous pharmaceutical compositions
KR101517415B1 (ko) * 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
EP2694076A4 (en) * 2011-04-01 2014-08-27 Cpex Pharmaceuticals Inc NASAL FORMULATIONS FROM BENZODIAZEPINE
JP2016171366A (ja) * 2015-03-11 2016-09-23 キヤノン株式会社 画像読取装置
AU2017248683A1 (en) * 2016-04-14 2018-10-25 Paion Uk Limited Orally inhaled and nasal benzodiazepines

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2906265A (en) † 1957-09-03 1959-09-29 Maryland Devices Inc Nasal adaptor for valved dispenser
US4153689A (en) † 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1604644A (en) * 1977-07-22 1981-12-09 Wellcome Found Biologically active pentapeptide amides
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4381773A (en) † 1980-06-23 1983-05-03 Schering Corporation Method and nozzle for nasal vaccination of immature mammals
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
EP0201537B1 (en) * 1984-10-23 1992-04-29 Nastech Pharmaceutical Company, Inc. Novel use of anti-nausea and anti-emetic pharmazeutical agents.
JPS61267528A (ja) † 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
JP2573275B2 (ja) * 1986-03-10 1997-01-22 ブルグハルト，クルト 薬学的製剤及びその製造法
US4786647A (en) * 1986-06-30 1988-11-22 University Of Florida Method for eliciting anxiolysis

Also Published As

Publication number Publication date
KR920005965B1 (ko) 1992-07-25
CA1336502C (en) 1995-08-01
DE68923697T3 (de) 2001-04-05
EP0386232B2 (en) 2000-09-06
WO1990002737A1 (en) 1990-03-22
US4950664A (en) 1990-08-21
KR900701252A (ko) 1990-12-01
AU4349989A (en) 1990-04-02
EP0386232B1 (en) 1995-08-02
ATE125799T1 (de) 1995-08-15
DK175710B1 (da) 2005-01-31
JPH03501390A (ja) 1991-03-28
NZ230653A (en) 1991-05-28
AU640618B2 (en) 1993-09-02
DK120390D0 (da) 1990-05-15
EP0386232A4 (en) 1991-03-13
EP0386232A1 (en) 1990-09-12
IL91656A0 (en) 1990-04-29
DE68923697D1 (de) 1995-09-07
JP2729525B2 (ja) 1998-03-18
DE68923697T2 (de) 1996-01-25

Similar Documents

Publication Publication Date Title
DK120390A (da) Nasal administration af benzodiazepinhypnotika
SV1997000049A (es) Conjugados de interferones ref. 12614 sv
MY119365A (en) Novel pharmaceutical combination
NO306377B1 (no) Doseform for avgivelse av et medikament
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
MY115662A (en) Novel compounds with analgesic effect
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
ATE198835T1 (de) Knochenwachstumsfördernde zusammensetzung
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
NZ237930A (en) Wafer for administration of medicaments through the sub-lingual mucosa
DE69833748D1 (de) Benzocycloheptha-thiophen verbindungen
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
ATE134294T1 (de) Zusammensetzung mit psyllium
MY101916A (en) Etoposide oral dosage form.
TR199900013T2 (xx) Yeni bile�ikler.
AR007058A1 (es) Uso de interferon en medicamentos y composiciones para contacto oromucosal
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
BE1002099A3 (fr) Nouvelles quinazolinones tetracycliques, leur preparation et leur utilisation comme medicaments.
NO902022L (no) Nasal administrering av benzodiazepin-sovemidler.
IT1235539B (it) Composti otticamente attivi a base di nicergolina aventi attivita' vasodilatatrice periferica, e loro composizioni farmaceutiche
KR890700580A (ko) 진경 작용을 갖는 제약 조성물
CS631190A3 (en) E1 prostaglandin in injection medicinal form

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK